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Setting Limits to Risk: Primum
non nocere (Now and Later)
Determining carcinogenic risk following
imaging radiation exposure is based most-
ly on predictive mathematical models
developed from empirical data provided
by large observational studies, such as the
large cohort study of Japanese atomic
bomb survivors [1]. The United Nations
Scientific Committee on the Effects of
Atomic Radiation (UNSCEAR) model
developed by the United Nations [2] and
the Biological Effects of Ionizing Radia-
tion (BEIR) VII model developed by the
US National Research Council [3] have
been validated for risk assessment using
smaller exposed cohorts, for example,
those of nuclear plant workers, the Cher-
nobyl population, workers exposed occu-
pationally, and patients undergoing med-
ical procedures involving radiation
exposure. In general, these models have
been used to establish maximum accept-
able levels of exposure and protection
guidelines in occupational environments
and for setting limits and safety standards
in radiodiagnostic and therapeutic expo-
sures [4]. In this issue of PLoS Medicine, Joel
Ray and colleagues report a large study
from Ontario, Canada that adds to our
growing understanding of cancer risk
following prenatal exposure to radiodiag-
nostic imaging [5].
Issues with Observational
Studies
The possibility that pre- or postnatal
exposure to radiation from diagnostic
imaging procedures increases cancer risk
is among the most controversial topics in
medicine [6–8]. The association of in utero
irradiation and increased risk of childhood
malignancies has been studied since the
1950s. Ionizing radiation has been shown
to cause leukaemia and solid tumours in
both exposed adults and children [1,7,9].
However, for in utero exposure the magni-
tude oftheriskfrom low-dose radiationand
whether risk varies throughout pregnancy
have been open to debate. Some support-
ing empirical data exist for the increased
risk of leukaemia [10], but the issue is far
from resolved despite numerous case-con-
trolandcohortstudies,and inspiteofmeta-
analyses that have attempted to provide
average risk effects [4,11].
The lack of a clear-cut picture rests on a
number of practical issues. First, the
average radiation dose from individual
diagnostic or therapeutic procedures has
historically declined owing to improve-
ments in the technology and equipment
safeguards. Although the number of imag-
ing procedures has increased over the
years, equipment efficiency has gradually
improved. As a consequence, more recent
studies that collected data based on plain
films with lower exposure doses are less
likely to detect associations than first
generation investigations. For computer-
ized tomographic (CT) scans, doses are
typically higher than those for ordinary
plain films and, although efficiency has
improved, the multiple slices commonly
taken in helical scans subject patients to
relatively higher overall doses than those
from first-generation plain films. Second,
childhood malignancies are very rare; thus
individual studies tend to lack the necessary
precision to detect low-level associations. A
case in point is the observation that among
some 800 atomic bomb survivors with
prenatal exposure, there were only two
cancer cases despite the prediction that 5–
14 extra deaths due to childhood cancers
were to be expected [12]. A third limitation
in many observational studies is the lack of
accurate exposure information with conse-
quent misclassification of the exposure dose
and attenuation of the associations. Having
anatomically relevant dosimetry data is
essential for interpreting findings. Calcula-
tion of relative risks (RR) separately for
radiation exposure to the abdomen and for
other body parts provides insights as to the
validityoftheassociationsasgenuine causal
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Ray J, Schull M, Urquia M, You J,
Guttman A, et al. (2010) Major
radiodiagnostic imaging in preg-
nancy and the risk of childhood
malignancy: A population-based
cohort study in Ontario. PLoS Med
7: 337. doi:10.1371/journal.pmed.
1000337
In a record linkage study, Joel Ray
and colleagues examine the associ-
ation between diagnostic imaging
during pregnancy and later child-
hood cancers.
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reliance on subject recall for exposure
ascertainment may lead to biases towards
positive associations. Perhaps not surpris-
ingly,forinutero exposure,studies showing
a statistically significant positive association
between diagnostic radiation and increased
childhood cancer risk have been case-
control studies. No cohort study has been
able to show the same relationship [4,6,11].
One would expect that meta-analyses
on the topic of prenatal exposures to
radiation for diagnostic imaging purposes
would have provided comparable findings.
The International Commission on Radia-
tion Protection (ICRP) concluded from the
compilation of seven case-control and four
cohort studies that there is a statistically
significant increase in risk for all cancers
(RR=1.40, 95% confidence interval [CI]
1.23–1.59) and for leukaemia, specifically
(RR=1.30, 95% CI 1.16–1.46), but a
weaker risk effect for solid tumours
(RR=1.14, 95% CI 0.94–1.40) [4]. A
Cochrane systematic review conducted in
2008, which included only studies pub-
lished between January 1990 and Decem-
ber 2006 (19 case-control and six cohort
studies), did not find an association
between prenatal exposures and leukae-
mia (RR=0.99; 95% CI 0.78–1.13) and
found at most weak effects for solid
tumours [11]. Interestingly, another meta-
analysis covering the same time span of
published studies found a weighted mean RR
of 1.16 (95% CI 1.00–1.36) for leukaemias,
possibly as a result of more judicious
weighting of abdominal exposures, whenever
available in the published studies [14].
Record Linkage to the Rescue
It is against the above backdrop of findings
spanning multiple eras of exposure dose that
the innovative study by Joel Ray and
colleagues [5] in this issue of PLoS Medicine
tries to advance our understanding of this
important public health concern. The au-
thors used a meticulous record linkage of
administrative and health care utilization
databases to identify all 1.8 million mother–
child pairs from 1991 to 2008 in Ontario,
Canada. They identified all term obstetrical
deliveries and newborn records, and inpa-
tient and outpatient major radiodiagnostic
services, and linked these data to the Ontario
tumour registry records to identify children
who developed a malignant tumour after
birth. There were four cancer cases among
the children of 5,590 mothers having
received anyformofradiodiagnosticimaging
procedure during pregnancy, versus 2,539
cases documented among the offspring of
1,829,927 mothers with no exposure. This
translates into a RR (with pregnancies as
denominators for rates) of 0.52. Most
importantly, however, the authors analyzed
the risk effect on the basis of the accrued
person–time denominators for all children.
This resulted in a crude hazard ratio [HR] of
0.69 (95% CI 0.26–1.82). Adjustment for a
priori confounders, such as maternal age,
income, urban status, maternal cancer,
infant sex, history of chromosomal or
congenital anomalies, and radiodiagnostic
exposure after birth, did not materially
change the association (HR=0.68, 95% CI
0.25–1.80). Because their study was popula-
tion-based and enrolled all eligible pregnan-
cy–child pairs in the province during the
accrual period, the incidence of childhood
cancers observed among those with radio-
diagnostic exposures represents a reduced
burden of disease. For external validity
purposes, however, the authors prudently
concluded that, although the point estimate
of the association was consistent with
reduced risk, the statistical boundaries gaug-
ing the precision of the measure prevented
them from ruling out a harmful effect from
prenatal irradiation from medical sources. As
an additional finding, the authors showed
that radiodiagnostic testing increased about
6-fold, from 1.1 to 6.3 per 1,000 pregnancies
during the nearlytwo decadescovered bythe
study, with nearly three-fourths of these
procedures being CT scans.
The Ontario study has several strengths
related to the sheer size of the investiga-
tion, the fact that it was population-based,
covered a relatively ‘‘modern’’ era of
efficient and low radiation dose delivery
to the target organs, had high-quality
exposure ascertainment not collected via
patient recall, and had sufficient follow-up
for late childhood onset malignancies. Yet,
the rarity of the outcome among exposed
children prevented the authors from
making more insightful analyses that could
have revealed dose–response trends or
permitted probing specifically for leukae-
mia risk. Likewise, with the low numbers
of childhood malignancies, the authors
could not examine the coherence of
exposure-risk effects by anatomical site,
thus comparing risk effects for exposures
when the foetus is in the field of view
(pelvis or abdominal) and when it receives
at most scattered radiation, as is the case
for imaging procedures involving only the
extremities. As with most cohort studies,
the Ontario investigation did not produce
statistical evidence for an increased risk of
childhood malignancies, but it provided
important baseline data. It is also note-
worthy that the Ontario investigation
raised the bar substantially for future
large-scale studies by showing the ways
in which clever record linkage of multiple
administrative and health care utilization
databases can be used for cost-effective
disease risk surveillance in a given setting.
Stratifying Exposure-Risk
Relations
The ongoing controversy about cancer
risk following prenatal exposure to radio-
diagnostic imaging has not been solved, but
there seems to be a general consensus that
diagnostic imaging poses a high risk of
inducing childhood malignancies and that
the null results must be interpreted careful-
ly. Diagnostic CT imaging radiation in-
volving the pelvis and the abdomen yields a
high dose to the foetus [13,15] and may
thus, at least theoretically, increase the risk
of childhood and even adult malignancies
[9] relative to imaging procedures taken
with the foetus outside of the field of view,
which provides negligible scattered radia-
tion exposure. Future studies should focus
on accurately stratifying risk on the basis of
this premise. We also believe that an
international consortium that attempts to
pool the data from the available investiga-
tions with the primary aim of categorizing
exposure-risk associations on the basis of
the magnitude of the dose delivered to the
foetus could shed much light into this issue
and assist policymakers in the future.
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